Banerjee Subhashis sold $5K of ARTV
Banerjee Subhashis (Chief Medical Officer) sold 1,110 shares of Artiva Biotherapeutics, Inc. (ARTV) at $4.18 on 2026-11-02.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and unlikely to move the stock significantly, but it provides transparency for investors.
Market read
A small insider sale that offers limited trading insight; most traders will likely ignore.
What to watch
No pre‑arranged 10b5‑1 plan; the CMO may be reallocating capital, which could be neutral or positive.
Background
Form 4 filing discloses insider transactions required by the SEC.
Ticker impact
Chief Medical Officer Banerjee Subhashis sold 1,110 shares for $4,641 on 2026-11-02.
likely pressure as the market prices in the insider sell
The sale is small relative to holdings (168,738 shares) and typical for a 10b5‑1 plan, but any CMO sell can be viewed negatively.
Market effects
Minimal impact on biotech sector; similar insider sales are routine.
None
Low
Counterpoint
The sale could be a routine liquidity event and not indicative of negative fundamentals.
Key entities
- companyArtiva Biotherapeutics, Inc.
US‑listed biotech company (ticker ARTV).
- personBanerjee Subhashis
Chief Medical Officer of Artiva Biotherapeutics.



